173 related articles for article (PubMed ID: 17299840)
1. Infliximab does not suppress the tuberculin skin test (purified protein derivative).
Hatemi G; Melikoglu M; Fresko I; Masatlioglu S; Tascilar K; Yazici H
J Rheumatol; 2007 Mar; 34(3):474-80. PubMed ID: 17299840
[TBL] [Abstract][Full Text] [Related]
2. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M
J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944
[TBL] [Abstract][Full Text] [Related]
3. Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy.
Wolfe F; Michaud K; Anderson J; Urbansky K
Arthritis Rheum; 2004 Feb; 50(2):372-9. PubMed ID: 14872478
[TBL] [Abstract][Full Text] [Related]
4. Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis.
Ponce de León D; Acevedo-Vásquez E; Sánchez-Torres A; Cucho M; Alfaro J; Perich R; Pastor C; Harrison J; Sánchez-Schwartz C
Ann Rheum Dis; 2005 Sep; 64(9):1360-1. PubMed ID: 16100342
[TBL] [Abstract][Full Text] [Related]
5. Low prevalence of reactive PPD prior to infliximab use: comparative study on a population sample of Hospital Geral de Fortaleza.
Callado MR; Lima JR; Nobre CA; Vieira WP
Rev Bras Reumatol; 2011; 51(1):40-52. PubMed ID: 21412605
[TBL] [Abstract][Full Text] [Related]
6. Tuberculin skin test results and the booster phenomenon in two-step tuberculin skin testing in hemodialysis patients.
Dogan E; Erkoc R; Sayarlioglu H; Uzun K
Ren Fail; 2005; 27(4):425-8. PubMed ID: 16060131
[TBL] [Abstract][Full Text] [Related]
7. Comparison of an in vitro tuberculosis interferon-gamma assay with delayed-type hypersensitivity testing for detection of latent Mycobacterium tuberculosis: a pilot study in rheumatoid arthritis.
Greenberg JD; Reddy SM; Schloss SG; Kurucz OS; Bartlett SJ; Abramson SB; Bingham CO
J Rheumatol; 2008 May; 35(5):770-5. PubMed ID: 18322990
[TBL] [Abstract][Full Text] [Related]
8. Documented tuberculin skin testing among infliximab users following a multi-modal risk communication interventions.
Shatin D; Rawson NS; Curtis JR; Braun MM; Martin CK; Moreland LW; Becker AF; Patkar NM; Allison JJ; Saag KG
Pharmacoepidemiol Drug Saf; 2006 Jan; 15(1):11-8. PubMed ID: 16136625
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of bovine cutaneous delayed-type hypersensitivity (DTH) to various test antigens and a mitogen using several adjuvants.
Hernández A; Yager JA; Wilkie BN; Leslie KE; Mallard BA
Vet Immunol Immunopathol; 2005 Mar; 104(1-2):45-58. PubMed ID: 15661330
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF-alpha blocking drugs using a novel flow-cytometric interferon-gamma release assay.
Dinser R; Fousse M; Sester U; Albrecht K; Singh M; Köhler H; Müller-Ladner U; Sester M
Rheumatology (Oxford); 2008 Feb; 47(2):212-8. PubMed ID: 18208824
[TBL] [Abstract][Full Text] [Related]
11. Sustained effect after lowering high-dose infliximab in patients with rheumatoid arthritis: a prospective dose titration study.
van den Bemt BJ; den Broeder AA; Snijders GF; Hekster YA; van Riel PL; Benraad B; Wolbink GJ; van den Hoogen FH
Ann Rheum Dis; 2008 Dec; 67(12):1697-701. PubMed ID: 18245109
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive assessment of arterial stiffness indices by applanation tonometry and pulse wave analysis in patients with rheumatoid arthritis treated with TNF-alpha blocker remicade (infliximab).
Cypiene A; Laucevicius A; Venalis A; Ryliskyte L; Dadoniene J; Petrulioniene Z; Kovaite M; Laskova V; Gintautas J
Proc West Pharmacol Soc; 2007; 50():119-22. PubMed ID: 18605247
[TBL] [Abstract][Full Text] [Related]
13. Tuberculin testing of kidney allograft recipients and donors before transplantation.
Khosroshahi HT; Shoja EA; Beiglu LG; Hassan AP
Transplant Proc; 2006 Sep; 38(7):1982-4. PubMed ID: 16979972
[TBL] [Abstract][Full Text] [Related]
14. Infliximab treatment in patients with rheumatoid arthritis and spondyloarthropathies in clinical practice: adverse events and other reasons for discontinuation of treatment.
Levälampi T; Korpela M; Vuolteenaho K; Moilanen E
Scand J Rheumatol; 2008; 37(1):6-12. PubMed ID: 18189188
[TBL] [Abstract][Full Text] [Related]
15. Safety of etanercept in patients at high risk for mycobacterial tuberculosis infections.
Aggarwal R; Manadan AM; Poliyedath A; Sequeira W; Block JA
J Rheumatol; 2009 May; 36(5):914-7. PubMed ID: 19332623
[TBL] [Abstract][Full Text] [Related]
16. Purified protein derivative response in juvenile idiopathic arthritis.
Kiray E; Kasapcopur O; Bas V; Kamburoglu-Goksel A; Midilli K; Arisoy N; Tastan Y
J Rheumatol; 2009 Sep; 36(9):2029-32. PubMed ID: 19648302
[TBL] [Abstract][Full Text] [Related]
17. A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab.
Marotte H; Pallot-Prades B; Grange L; Gaudin P; Alexandre C; Miossec P
Arthritis Res Ther; 2007; 9(3):R61. PubMed ID: 17597527
[TBL] [Abstract][Full Text] [Related]
18. Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials.
Doyle MK; Rahman MU; Han C; Han J; Giles J; Bingham CO; Bathon J
Semin Arthritis Rheum; 2009 Oct; 39(2):123-31. PubMed ID: 18823645
[TBL] [Abstract][Full Text] [Related]
19. Screening of cellular immunity in patients with rheumatoid arthritis by phytohaemagglutinin skin test.
Kaćaki J; Budimir M; Berović Z
Rheumatology; 1975; 6():72-9. PubMed ID: 1202609
[TBL] [Abstract][Full Text] [Related]
20. Correlation of CX3CL1 and CX3CR1 levels with response to infliximab therapy in patients with rheumatoid arthritis.
Odai T; Matsunawa M; Takahashi R; Wakabayashi K; Isozaki T; Yajima N; Miwa Y; Kasama T
J Rheumatol; 2009 Jun; 36(6):1158-65. PubMed ID: 19369458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
